These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8759066)

  • 1. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.
    Lamarche B; Moorjani S; Lupien PJ; Cantin B; Bernard PM; Dagenais GR; Després JP
    Circulation; 1996 Aug; 94(3):273-8. PubMed ID: 8759066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.
    Lamarche B; Tchernof A; Mauriège P; Cantin B; Dagenais GR; Lupien PJ; Després JP
    JAMA; 1998 Jun; 279(24):1955-61. PubMed ID: 9643858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.
    Sweetnam PM; Bolton CH; Downs LG; Durrington PN; MacKness MI; Elwood PC; Yarnell JW
    Eur J Clin Invest; 2000 Nov; 30(11):947-56. PubMed ID: 11114956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.
    Pirro M; Mauriège P; Tchernof A; Cantin B; Dagenais GR; Després JP; Lamarche B
    Atherosclerosis; 2002 Feb; 160(2):377-84. PubMed ID: 11849661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.
    Couillard C; Lamarche B; Mauriège P; Cantin B; Dagenais GR; Moorjani S; Lupien PJ; Després JP
    Diabetes Care; 1998 May; 21(5):782-6. PubMed ID: 9589240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.
    Lamarche B; Tchernof A; Moorjani S; Cantin B; Dagenais GR; Lupien PJ; Després JP
    Circulation; 1997 Jan; 95(1):69-75. PubMed ID: 8994419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
    Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
    Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error.
    Egger M; Smith GD; Pfluger D; Altpeter E; Elwood PC
    Atherosclerosis; 1999 Apr; 143(2):275-84. PubMed ID: 10217356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study.
    Lamarche B; Després JP; Moorjani S; Cantin B; Dagenais GR; Lupien PJ
    Atherosclerosis; 1996 Jan; 119(2):235-45. PubMed ID: 8808500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
    Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoproteins and ischaemic heart disease: implications for screening.
    Wald NJ; Law M; Watt HC; Wu T; Bailey A; Johnson AM; Craig WY; Ledue TB; Haddow JE
    Lancet; 1994 Jan; 343(8889):75-9. PubMed ID: 7903777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein-cholesterol and ischemic heart disease risk in Korean men with cardiac risk.
    Linton JA; Kimm H; Ohrr H; Park IS; Jee SH
    Circ J; 2009 Jul; 73(7):1296-301. PubMed ID: 19443957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project.
    Gardner CD; Tribble DL; Young DR; Ahn D; Fortmann SP
    Prev Med; 2000 Oct; 31(4):346-56. PubMed ID: 11006059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.
    Koren-Morag N; Goldbourt U; Graff E; Tanne D
    J Neurol Sci; 2008 Jul; 270(1-2):82-7. PubMed ID: 18377938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).
    Tynkkynen J; Hernesniemi JA; Laatikainen T; Havulinna AS; Sundvall J; Leiviskä J; Salo P; Salomaa V
    Age (Dordr); 2016 Dec; 38(5-6):465-473. PubMed ID: 27663235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.